nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—ADRA1B—vas deferens—prostate cancer	0.16	0.843	CbGeAlD
Propericiazine—ADRA1B—renal system—prostate cancer	0.00976	0.0513	CbGeAlD
Propericiazine—ADRA2A—prostate gland—prostate cancer	0.00612	0.0322	CbGeAlD
Propericiazine—ADRA2A—seminal vesicle—prostate cancer	0.00518	0.0272	CbGeAlD
Propericiazine—ADRA2A—urethra—prostate cancer	0.0041	0.0215	CbGeAlD
Propericiazine—ADRA2A—testis—prostate cancer	0.0027	0.0142	CbGeAlD
Propericiazine—ADRA2A—lymph node—prostate cancer	0.00195	0.0103	CbGeAlD
Propericiazine—Perphenazine—AOX1—prostate cancer	0.0014	0.108	CrCbGaD
Propericiazine—Domperidone—CYP3A5—prostate cancer	0.000838	0.0649	CrCbGaD
Propericiazine—Acepromazine—SLC22A1—prostate cancer	0.000778	0.0602	CrCbGaD
Propericiazine—Thioproperazine—SLC22A1—prostate cancer	0.00076	0.0589	CrCbGaD
Propericiazine—Infection—Goserelin—prostate cancer	0.000749	0.00109	CcSEcCtD
Propericiazine—Thiothixene—SLC22A1—prostate cancer	0.000748	0.0579	CrCbGaD
Propericiazine—Pipotiazine—SLC22A1—prostate cancer	0.000748	0.0579	CrCbGaD
Propericiazine—Oedema—Conjugated Estrogens—prostate cancer	0.000747	0.00109	CcSEcCtD
Propericiazine—Infection—Conjugated Estrogens—prostate cancer	0.000742	0.00108	CcSEcCtD
Propericiazine—Diarrhoea—Bicalutamide—prostate cancer	0.000742	0.00108	CcSEcCtD
Propericiazine—Tachycardia—Goserelin—prostate cancer	0.000736	0.00107	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—prostate cancer	0.000731	0.00106	CcSEcCtD
Propericiazine—Hyperhidrosis—Goserelin—prostate cancer	0.000729	0.00106	CcSEcCtD
Propericiazine—Tachycardia—Conjugated Estrogens—prostate cancer	0.000729	0.00106	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—prostate cancer	0.000728	0.00106	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—prostate cancer	0.000728	0.00106	CcSEcCtD
Propericiazine—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000724	0.00105	CcSEcCtD
Propericiazine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000722	0.00105	CcSEcCtD
Propericiazine—Increased appetite—Prednisone—prostate cancer	0.000719	0.00105	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—prostate cancer	0.000717	0.00104	CcSEcCtD
Propericiazine—Jaundice—Etoposide—prostate cancer	0.000708	0.00103	CcSEcCtD
Propericiazine—Hypotension—Goserelin—prostate cancer	0.000705	0.00102	CcSEcCtD
Propericiazine—Arrhythmia—Mitoxantrone—prostate cancer	0.000701	0.00102	CcSEcCtD
Propericiazine—Hypotension—Conjugated Estrogens—prostate cancer	0.000698	0.00102	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—prostate cancer	0.000695	0.00101	CcSEcCtD
Propericiazine—Hypokalaemia—Capecitabine—prostate cancer	0.00069	0.001	CcSEcCtD
Propericiazine—Vomiting—Bicalutamide—prostate cancer	0.000689	0.001	CcSEcCtD
Propericiazine—Tremor—Estradiol—prostate cancer	0.000686	0.000998	CcSEcCtD
Propericiazine—Rash—Bicalutamide—prostate cancer	0.000684	0.000994	CcSEcCtD
Propericiazine—Dermatitis—Bicalutamide—prostate cancer	0.000683	0.000993	CcSEcCtD
Propericiazine—Insomnia—Goserelin—prostate cancer	0.000682	0.000992	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—prostate cancer	0.000678	0.000986	CcSEcCtD
Propericiazine—Insomnia—Conjugated Estrogens—prostate cancer	0.000676	0.000983	CcSEcCtD
Propericiazine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000675	0.000982	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—prostate cancer	0.000674	0.00098	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—prostate cancer	0.000674	0.00098	CcSEcCtD
Propericiazine—Agitation—Estradiol—prostate cancer	0.000673	0.000979	CcSEcCtD
Propericiazine—Dyspnoea—Goserelin—prostate cancer	0.000672	0.000978	CcSEcCtD
Propericiazine—Somnolence—Goserelin—prostate cancer	0.000671	0.000975	CcSEcCtD
Propericiazine—Angioedema—Estradiol—prostate cancer	0.000669	0.000973	CcSEcCtD
Propericiazine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000666	0.000969	CcSEcCtD
Propericiazine—Somnolence—Conjugated Estrogens—prostate cancer	0.000664	0.000966	CcSEcCtD
Propericiazine—Asthma—Capecitabine—prostate cancer	0.000656	0.000953	CcSEcCtD
Propericiazine—Constipation—Goserelin—prostate cancer	0.000645	0.000938	CcSEcCtD
Propericiazine—Nausea—Bicalutamide—prostate cancer	0.000644	0.000936	CcSEcCtD
Propericiazine—Vision blurred—Mitoxantrone—prostate cancer	0.000643	0.000935	CcSEcCtD
Propericiazine—Clomipramine—GSTP1—prostate cancer	0.000639	0.0495	CrCbGaD
Propericiazine—Constipation—Conjugated Estrogens—prostate cancer	0.000639	0.000929	CcSEcCtD
Propericiazine—Sweating increased—Capecitabine—prostate cancer	0.000639	0.000929	CcSEcCtD
Propericiazine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000627	0.000912	CcSEcCtD
Propericiazine—Perphenazine—CYP2C18—prostate cancer	0.000626	0.0485	CrCbGaD
Propericiazine—Weight increased—Docetaxel—prostate cancer	0.000616	0.000896	CcSEcCtD
Propericiazine—Hypokalaemia—Prednisone—prostate cancer	0.000615	0.000894	CcSEcCtD
Propericiazine—Dry mouth—Estradiol—prostate cancer	0.00061	0.000887	CcSEcCtD
Propericiazine—Pneumonia—Docetaxel—prostate cancer	0.000607	0.000883	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—prostate cancer	0.000605	0.00088	CcSEcCtD
Propericiazine—Confusional state—Estradiol—prostate cancer	0.000603	0.000877	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—prostate cancer	0.000602	0.000875	CcSEcCtD
Propericiazine—Photosensitivity reaction—Capecitabine—prostate cancer	0.000599	0.00087	CcSEcCtD
Propericiazine—Oedema—Estradiol—prostate cancer	0.000598	0.000869	CcSEcCtD
Propericiazine—Weight increased—Capecitabine—prostate cancer	0.000597	0.000868	CcSEcCtD
Propericiazine—Body temperature increased—Goserelin—prostate cancer	0.000596	0.000867	CcSEcCtD
Propericiazine—Infection—Estradiol—prostate cancer	0.000594	0.000864	CcSEcCtD
Propericiazine—Hyperglycaemia—Capecitabine—prostate cancer	0.000591	0.00086	CcSEcCtD
Propericiazine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000591	0.000859	CcSEcCtD
Propericiazine—Jaundice—Docetaxel—prostate cancer	0.000589	0.000856	CcSEcCtD
Propericiazine—Pneumonia—Capecitabine—prostate cancer	0.000588	0.000855	CcSEcCtD
Propericiazine—Tachycardia—Estradiol—prostate cancer	0.000584	0.000849	CcSEcCtD
Propericiazine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000583	0.000847	CcSEcCtD
Propericiazine—Hyperhidrosis—Estradiol—prostate cancer	0.000578	0.000841	CcSEcCtD
Propericiazine—Rash—Ethinyl Estradiol—prostate cancer	0.000578	0.00084	CcSEcCtD
Propericiazine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000577	0.000839	CcSEcCtD
Propericiazine—Jaundice—Capecitabine—prostate cancer	0.00057	0.000829	CcSEcCtD
Propericiazine—Sweating increased—Prednisone—prostate cancer	0.000569	0.000827	CcSEcCtD
Propericiazine—Agranulocytosis—Docetaxel—prostate cancer	0.000564	0.000819	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—prostate cancer	0.000563	0.000818	CcSEcCtD
Propericiazine—Confusional state—Mitoxantrone—prostate cancer	0.000562	0.000817	CcSEcCtD
Propericiazine—Oedema—Mitoxantrone—prostate cancer	0.000557	0.00081	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—prostate cancer	0.000557	0.00081	CcSEcCtD
Propericiazine—Hypersensitivity—Goserelin—prostate cancer	0.000556	0.000808	CcSEcCtD
Propericiazine—Infection—Mitoxantrone—prostate cancer	0.000553	0.000805	CcSEcCtD
Propericiazine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00055	0.0008	CcSEcCtD
Propericiazine—Agranulocytosis—Capecitabine—prostate cancer	0.000546	0.000793	CcSEcCtD
Propericiazine—Nausea—Ethinyl Estradiol—prostate cancer	0.000544	0.000792	CcSEcCtD
Propericiazine—Tachycardia—Mitoxantrone—prostate cancer	0.000544	0.000791	CcSEcCtD
Propericiazine—Insomnia—Estradiol—prostate cancer	0.000541	0.000786	CcSEcCtD
Propericiazine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000539	0.000783	CcSEcCtD
Propericiazine—Erectile dysfunction—Prednisone—prostate cancer	0.000538	0.000782	CcSEcCtD
Propericiazine—Dyspnoea—Estradiol—prostate cancer	0.000533	0.000775	CcSEcCtD
Propericiazine—Somnolence—Estradiol—prostate cancer	0.000532	0.000773	CcSEcCtD
Propericiazine—Weight increased—Prednisone—prostate cancer	0.000532	0.000773	CcSEcCtD
Propericiazine—Hyperglycaemia—Prednisone—prostate cancer	0.000527	0.000766	CcSEcCtD
Propericiazine—Hypotension—Mitoxantrone—prostate cancer	0.000521	0.000757	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—prostate cancer	0.000521	0.000757	CcSEcCtD
Propericiazine—Diarrhoea—Goserelin—prostate cancer	0.000516	0.00075	CcSEcCtD
Propericiazine—Constipation—Estradiol—prostate cancer	0.000511	0.000743	CcSEcCtD
Propericiazine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000511	0.000743	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—prostate cancer	0.000503	0.000732	CcSEcCtD
Propericiazine—Dyspnoea—Mitoxantrone—prostate cancer	0.000497	0.000722	CcSEcCtD
Propericiazine—Somnolence—Mitoxantrone—prostate cancer	0.000495	0.00072	CcSEcCtD
Propericiazine—Cardiac disorder—Capecitabine—prostate cancer	0.000487	0.000708	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—prostate cancer	0.000484	0.000704	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—prostate cancer	0.000481	0.000699	CcSEcCtD
Propericiazine—Vomiting—Goserelin—prostate cancer	0.00048	0.000697	CcSEcCtD
Propericiazine—Constipation—Mitoxantrone—prostate cancer	0.000476	0.000693	CcSEcCtD
Propericiazine—Rash—Goserelin—prostate cancer	0.000476	0.000692	CcSEcCtD
Propericiazine—Dermatitis—Goserelin—prostate cancer	0.000475	0.000691	CcSEcCtD
Propericiazine—Vomiting—Conjugated Estrogens—prostate cancer	0.000475	0.000691	CcSEcCtD
Propericiazine—Body temperature increased—Estradiol—prostate cancer	0.000473	0.000687	CcSEcCtD
Propericiazine—Rash—Conjugated Estrogens—prostate cancer	0.000471	0.000685	CcSEcCtD
Propericiazine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000471	0.000684	CcSEcCtD
Propericiazine—Arrhythmia—Capecitabine—prostate cancer	0.000469	0.000682	CcSEcCtD
Propericiazine—Confusional state—Etoposide—prostate cancer	0.000467	0.000679	CcSEcCtD
Propericiazine—Infection—Etoposide—prostate cancer	0.00046	0.000669	CcSEcCtD
Propericiazine—Asthma—Epirubicin—prostate cancer	0.000457	0.000664	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—prostate cancer	0.000452	0.000658	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—prostate cancer	0.000452	0.000658	CcSEcCtD
Propericiazine—Nausea—Goserelin—prostate cancer	0.000448	0.000651	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—prostate cancer	0.000448	0.000651	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—prostate cancer	0.000445	0.000647	CcSEcCtD
Propericiazine—Nausea—Conjugated Estrogens—prostate cancer	0.000444	0.000645	CcSEcCtD
Propericiazine—Hypersensitivity—Estradiol—prostate cancer	0.000441	0.000641	CcSEcCtD
Propericiazine—Body temperature increased—Mitoxantrone—prostate cancer	0.00044	0.00064	CcSEcCtD
Propericiazine—Hypotension—Etoposide—prostate cancer	0.000433	0.00063	CcSEcCtD
Propericiazine—Vision blurred—Capecitabine—prostate cancer	0.000431	0.000626	CcSEcCtD
Propericiazine—Tremor—Capecitabine—prostate cancer	0.000428	0.000622	CcSEcCtD
Propericiazine—Alimemazine—CYP3A4—prostate cancer	0.000426	0.033	CrCbGaD
Propericiazine—Asthma—Doxorubicin—prostate cancer	0.000423	0.000615	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—prostate cancer	0.000418	0.000609	CcSEcCtD
Propericiazine—Arrhythmia—Prednisone—prostate cancer	0.000418	0.000607	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—prostate cancer	0.000417	0.000606	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—prostate cancer	0.000416	0.000604	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—prostate cancer	0.000413	0.000601	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—prostate cancer	0.000412	0.000599	CcSEcCtD
Propericiazine—Somnolence—Etoposide—prostate cancer	0.000412	0.000599	CcSEcCtD
Propericiazine—Pipotiazine—CYP2C19—prostate cancer	0.000411	0.0318	CrCbGaD
Propericiazine—Hypersensitivity—Mitoxantrone—prostate cancer	0.00041	0.000597	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—prostate cancer	0.00041	0.000596	CcSEcCtD
Propericiazine—Diarrhoea—Estradiol—prostate cancer	0.000409	0.000595	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—prostate cancer	0.000407	0.000592	CcSEcCtD
Propericiazine—Chlorpromazine—SLC22A1—prostate cancer	0.000405	0.0314	CrCbGaD
Propericiazine—Quetiapine—CYP3A5—prostate cancer	0.000404	0.0313	CrCbGaD
Propericiazine—Jaundice—Epirubicin—prostate cancer	0.000397	0.000577	CcSEcCtD
Propericiazine—Constipation—Etoposide—prostate cancer	0.000396	0.000576	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—prostate cancer	0.000393	0.000571	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—prostate cancer	0.000388	0.000565	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000386	0.000561	CcSEcCtD
Propericiazine—Oedema—Docetaxel—prostate cancer	0.000385	0.00056	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—prostate cancer	0.000385	0.000559	CcSEcCtD
Propericiazine—Vision blurred—Prednisone—prostate cancer	0.000384	0.000558	CcSEcCtD
Propericiazine—Infection—Docetaxel—prostate cancer	0.000383	0.000556	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—prostate cancer	0.000381	0.000554	CcSEcCtD
Propericiazine—Diarrhoea—Mitoxantrone—prostate cancer	0.000381	0.000554	CcSEcCtD
Propericiazine—Dry mouth—Capecitabine—prostate cancer	0.00038	0.000553	CcSEcCtD
Propericiazine—Vomiting—Estradiol—prostate cancer	0.00038	0.000553	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—prostate cancer	0.00038	0.000553	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—prostate cancer	0.000379	0.000551	CcSEcCtD
Propericiazine—Rash—Estradiol—prostate cancer	0.000377	0.000548	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—prostate cancer	0.000377	0.000548	CcSEcCtD
Propericiazine—Dermatitis—Estradiol—prostate cancer	0.000377	0.000548	CcSEcCtD
Propericiazine—Confusional state—Capecitabine—prostate cancer	0.000376	0.000547	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—prostate cancer	0.000376	0.000547	CcSEcCtD
Propericiazine—Agitation—Prednisone—prostate cancer	0.000374	0.000544	CcSEcCtD
Propericiazine—Oedema—Capecitabine—prostate cancer	0.000373	0.000542	CcSEcCtD
Propericiazine—Angioedema—Prednisone—prostate cancer	0.000372	0.000541	CcSEcCtD
Propericiazine—Infection—Capecitabine—prostate cancer	0.00037	0.000539	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—prostate cancer	0.000367	0.000534	CcSEcCtD
Propericiazine—Mequitazine—CYP3A4—prostate cancer	0.000367	0.0284	CrCbGaD
Propericiazine—Body temperature increased—Etoposide—prostate cancer	0.000366	0.000533	CcSEcCtD
Propericiazine—Tachycardia—Capecitabine—prostate cancer	0.000364	0.000529	CcSEcCtD
Propericiazine—Domperidone—CYP3A4—prostate cancer	0.000363	0.0281	CrCbGaD
Propericiazine—Hyperhidrosis—Capecitabine—prostate cancer	0.00036	0.000524	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—prostate cancer	0.00036	0.000523	CcSEcCtD
Propericiazine—Fluphenazine—CYP2E1—prostate cancer	0.000358	0.0278	CrCbGaD
Propericiazine—Nausea—Estradiol—prostate cancer	0.000355	0.000516	CcSEcCtD
Propericiazine—Vomiting—Mitoxantrone—prostate cancer	0.000354	0.000515	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—prostate cancer	0.000352	0.000511	CcSEcCtD
Propericiazine—Rash—Mitoxantrone—prostate cancer	0.000351	0.000511	CcSEcCtD
Propericiazine—Dermatitis—Mitoxantrone—prostate cancer	0.000351	0.00051	CcSEcCtD
Propericiazine—Hypotension—Capecitabine—prostate cancer	0.000348	0.000507	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—prostate cancer	0.000348	0.000507	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—prostate cancer	0.000343	0.000499	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—prostate cancer	0.000342	0.000498	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—prostate cancer	0.000341	0.000496	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—prostate cancer	0.000339	0.000493	CcSEcCtD
Propericiazine—Insomnia—Capecitabine—prostate cancer	0.000337	0.00049	CcSEcCtD
Propericiazine—Dyspnoea—Capecitabine—prostate cancer	0.000332	0.000483	CcSEcCtD
Propericiazine—Oedema—Prednisone—prostate cancer	0.000332	0.000483	CcSEcCtD
Propericiazine—Nausea—Mitoxantrone—prostate cancer	0.000331	0.000481	CcSEcCtD
Propericiazine—Infection—Prednisone—prostate cancer	0.00033	0.00048	CcSEcCtD
Propericiazine—Constipation—Docetaxel—prostate cancer	0.000329	0.000479	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—prostate cancer	0.000327	0.000475	CcSEcCtD
Propericiazine—Clomipramine—CYP2C19—prostate cancer	0.000325	0.0251	CrCbGaD
Propericiazine—Tachycardia—Prednisone—prostate cancer	0.000324	0.000471	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisone—prostate cancer	0.000321	0.000467	CcSEcCtD
Propericiazine—Constipation—Capecitabine—prostate cancer	0.000319	0.000464	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—prostate cancer	0.000317	0.000461	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—prostate cancer	0.000314	0.000457	CcSEcCtD
Propericiazine—Thioridazine—CYP2E1—prostate cancer	0.000309	0.0239	CrCbGaD
Propericiazine—Thioridazine—CYP2C19—prostate cancer	0.000306	0.0237	CrCbGaD
Propericiazine—Body temperature increased—Docetaxel—prostate cancer	0.000304	0.000443	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—prostate cancer	0.000302	0.000439	CcSEcCtD
Propericiazine—Insomnia—Prednisone—prostate cancer	0.0003	0.000437	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—prostate cancer	0.0003	0.000436	CcSEcCtD
Propericiazine—Methotrimeprazine—CYP2E1—prostate cancer	0.000295	0.0228	CrCbGaD
Propericiazine—Body temperature increased—Capecitabine—prostate cancer	0.000295	0.000429	CcSEcCtD
Propericiazine—Vomiting—Etoposide—prostate cancer	0.000295	0.000428	CcSEcCtD
Propericiazine—Agitation—Epirubicin—prostate cancer	0.000292	0.000425	CcSEcCtD
Propericiazine—Rash—Etoposide—prostate cancer	0.000292	0.000425	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—prostate cancer	0.000292	0.000424	CcSEcCtD
Propericiazine—Constipation—Prednisone—prostate cancer	0.000284	0.000413	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—prostate cancer	0.000284	0.000413	CcSEcCtD
Propericiazine—Perphenazine—CYP2C19—prostate cancer	0.000281	0.0217	CrCbGaD
Propericiazine—Vision blurred—Doxorubicin—prostate cancer	0.000278	0.000404	CcSEcCtD
Propericiazine—Nausea—Etoposide—prostate cancer	0.000275	0.0004	CcSEcCtD
Propericiazine—Quetiapine—CYP2C19—prostate cancer	0.000275	0.0213	CrCbGaD
Propericiazine—Hypersensitivity—Capecitabine—prostate cancer	0.000275	0.000399	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—prostate cancer	0.000271	0.000394	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—prostate cancer	0.000265	0.000385	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—prostate cancer	0.000264	0.000383	CcSEcCtD
Propericiazine—Body temperature increased—Prednisone—prostate cancer	0.000263	0.000382	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—prostate cancer	0.000262	0.000381	CcSEcCtD
Propericiazine—Pipotiazine—CYP3A4—prostate cancer	0.000261	0.0202	CrCbGaD
Propericiazine—Oedema—Epirubicin—prostate cancer	0.00026	0.000378	CcSEcCtD
Propericiazine—Infection—Epirubicin—prostate cancer	0.000258	0.000375	CcSEcCtD
Propericiazine—Diarrhoea—Capecitabine—prostate cancer	0.000255	0.000371	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—prostate cancer	0.000254	0.000369	CcSEcCtD
Propericiazine—Promazine—CYP2C19—prostate cancer	0.000253	0.0196	CrCbGaD
Propericiazine—Hyperhidrosis—Epirubicin—prostate cancer	0.000251	0.000365	CcSEcCtD
Propericiazine—Prochlorperazine—CYP3A4—prostate cancer	0.00025	0.0193	CrCbGaD
Propericiazine—Dry mouth—Doxorubicin—prostate cancer	0.000245	0.000357	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—prostate cancer	0.000245	0.000356	CcSEcCtD
Propericiazine—Hypersensitivity—Prednisone—prostate cancer	0.000245	0.000356	CcSEcCtD
Propericiazine—Rash—Docetaxel—prostate cancer	0.000243	0.000353	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—prostate cancer	0.000243	0.000353	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—prostate cancer	0.000243	0.000353	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—prostate cancer	0.000242	0.000352	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—prostate cancer	0.00024	0.00035	CcSEcCtD
Propericiazine—Infection—Doxorubicin—prostate cancer	0.000239	0.000347	CcSEcCtD
Propericiazine—Vomiting—Capecitabine—prostate cancer	0.000237	0.000345	CcSEcCtD
Propericiazine—Rash—Capecitabine—prostate cancer	0.000235	0.000342	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—prostate cancer	0.000235	0.000342	CcSEcCtD
Propericiazine—Dermatitis—Capecitabine—prostate cancer	0.000235	0.000342	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—prostate cancer	0.000235	0.000341	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000232	0.000338	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—prostate cancer	0.000232	0.000337	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—prostate cancer	0.000231	0.000336	CcSEcCtD
Propericiazine—Nausea—Docetaxel—prostate cancer	0.000229	0.000333	CcSEcCtD
Propericiazine—Diarrhoea—Prednisone—prostate cancer	0.000227	0.00033	CcSEcCtD
Propericiazine—Chlorpromazine—CYP2E1—prostate cancer	0.000225	0.0174	CrCbGaD
Propericiazine—Hypotension—Doxorubicin—prostate cancer	0.000225	0.000327	CcSEcCtD
Propericiazine—Constipation—Epirubicin—prostate cancer	0.000222	0.000323	CcSEcCtD
Propericiazine—Nausea—Capecitabine—prostate cancer	0.000221	0.000322	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—prostate cancer	0.000217	0.000316	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—prostate cancer	0.000214	0.000312	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—prostate cancer	0.000214	0.000311	CcSEcCtD
Propericiazine—Vomiting—Prednisone—prostate cancer	0.000211	0.000307	CcSEcCtD
Propericiazine—Rash—Prednisone—prostate cancer	0.000209	0.000305	CcSEcCtD
Propericiazine—Dermatitis—Prednisone—prostate cancer	0.000209	0.000304	CcSEcCtD
Propericiazine—Clomipramine—CYP3A4—prostate cancer	0.000206	0.016	CrCbGaD
Propericiazine—Constipation—Doxorubicin—prostate cancer	0.000206	0.000299	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—prostate cancer	0.000205	0.000299	CcSEcCtD
Propericiazine—Nausea—Prednisone—prostate cancer	0.000197	0.000287	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—prostate cancer	0.000191	0.000278	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—prostate cancer	0.00019	0.000276	CcSEcCtD
Propericiazine—Perphenazine—CYP3A4—prostate cancer	0.000178	0.0138	CrCbGaD
Propericiazine—Diarrhoea—Epirubicin—prostate cancer	0.000178	0.000258	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—prostate cancer	0.000177	0.000257	CcSEcCtD
Propericiazine—Quetiapine—CYP3A4—prostate cancer	0.000175	0.0136	CrCbGaD
Propericiazine—Vomiting—Epirubicin—prostate cancer	0.000165	0.00024	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—prostate cancer	0.000164	0.000239	CcSEcCtD
Propericiazine—Rash—Epirubicin—prostate cancer	0.000164	0.000238	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—prostate cancer	0.000164	0.000238	CcSEcCtD
Propericiazine—Promazine—CYP3A4—prostate cancer	0.000161	0.0125	CrCbGaD
Propericiazine—Nausea—Epirubicin—prostate cancer	0.000154	0.000224	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—prostate cancer	0.000153	0.000222	CcSEcCtD
Propericiazine—Rash—Doxorubicin—prostate cancer	0.000152	0.00022	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—prostate cancer	0.000151	0.00022	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—prostate cancer	0.000143	0.000208	CcSEcCtD
Propericiazine—Chlorpromazine—CYP3A4—prostate cancer	0.000142	0.011	CrCbGaD
Propericiazine—DRD1—Signaling Pathways—PDGFRB—prostate cancer	3.21e-05	0.000294	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NCOA1—prostate cancer	3.18e-05	0.000292	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CB—prostate cancer	3.18e-05	0.000291	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCZ—prostate cancer	3.16e-05	0.000289	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP19A1—prostate cancer	3.14e-05	0.000287	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ITGB3—prostate cancer	3.13e-05	0.000287	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF10—prostate cancer	3.09e-05	0.000283	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CG—prostate cancer	3.09e-05	0.000283	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—EP300—prostate cancer	3.09e-05	0.000283	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB2—prostate cancer	3.06e-05	0.00028	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—prostate cancer	3.06e-05	0.00028	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGFR4—prostate cancer	3.05e-05	0.000279	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PARP1—prostate cancer	3.05e-05	0.000279	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB3—prostate cancer	3.04e-05	0.000278	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGFR2—prostate cancer	3.03e-05	0.000278	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—RXRA—prostate cancer	3.03e-05	0.000277	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—JAK2—prostate cancer	3.02e-05	0.000277	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALCA—prostate cancer	3.01e-05	0.000276	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAP2K1—prostate cancer	3.01e-05	0.000275	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SRC—prostate cancer	3e-05	0.000275	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CD—prostate cancer	2.99e-05	0.000274	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VAV3—prostate cancer	2.98e-05	0.000273	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL12—prostate cancer	2.94e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFBR2—prostate cancer	2.94e-05	0.000269	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—prostate cancer	2.92e-05	0.000268	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL2—prostate cancer	2.92e-05	0.000267	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—COMT—prostate cancer	2.92e-05	0.000267	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TERT—prostate cancer	2.91e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTP1—prostate cancer	2.9e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ITPR1—prostate cancer	2.9e-05	0.000265	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CB—prostate cancer	2.87e-05	0.000263	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ITPR1—prostate cancer	2.86e-05	0.000262	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CG—prostate cancer	2.8e-05	0.000257	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HIF1A—prostate cancer	2.78e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP9—prostate cancer	2.77e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1R—prostate cancer	2.77e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—prostate cancer	2.76e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—JAK2—prostate cancer	2.74e-05	0.000251	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—prostate cancer	2.72e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CD—prostate cancer	2.72e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TYMS—prostate cancer	2.7e-05	0.000247	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CAV1—prostate cancer	2.69e-05	0.000246	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCQ—prostate cancer	2.69e-05	0.000246	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NGFR—prostate cancer	2.69e-05	0.000246	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—prostate cancer	2.68e-05	0.000246	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—prostate cancer	2.67e-05	0.000244	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KDR—prostate cancer	2.66e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAP3K7—prostate cancer	2.65e-05	0.000243	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LPL—prostate cancer	2.65e-05	0.000243	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2—prostate cancer	2.63e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDGFRB—prostate cancer	2.63e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LPL—prostate cancer	2.62e-05	0.00024	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CB—prostate cancer	2.6e-05	0.000238	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—prostate cancer	2.59e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ITGB3—prostate cancer	2.56e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF10—prostate cancer	2.55e-05	0.000234	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BAD—prostate cancer	2.53e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A1—prostate cancer	2.53e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB2—prostate cancer	2.53e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ERCC2—prostate cancer	2.51e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—prostate cancer	2.5e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—JAK2—prostate cancer	2.49e-05	0.000228	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB3—prostate cancer	2.49e-05	0.000228	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—KRAS—prostate cancer	2.48e-05	0.000228	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGFR2—prostate cancer	2.48e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAP2K1—prostate cancer	2.48e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CD—prostate cancer	2.47e-05	0.000226	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VAV3—prostate cancer	2.46e-05	0.000226	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—prostate cancer	2.45e-05	0.000225	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APC—prostate cancer	2.45e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFBR2—prostate cancer	2.43e-05	0.000222	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS1—prostate cancer	2.42e-05	0.000222	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGF—prostate cancer	2.42e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL2—prostate cancer	2.39e-05	0.000219	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITPR1—prostate cancer	2.39e-05	0.000219	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TERT—prostate cancer	2.38e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CB—prostate cancer	2.37e-05	0.000217	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—prostate cancer	2.36e-05	0.000216	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GSK3B—prostate cancer	2.35e-05	0.000215	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—prostate cancer	2.32e-05	0.000213	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARA—prostate cancer	2.31e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1R—prostate cancer	2.28e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—prostate cancer	2.28e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—prostate cancer	2.28e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—prostate cancer	2.27e-05	0.000208	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CREBBP—prostate cancer	2.27e-05	0.000208	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—JAK2—prostate cancer	2.26e-05	0.000207	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—prostate cancer	2.24e-05	0.000206	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—prostate cancer	2.23e-05	0.000205	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—prostate cancer	2.22e-05	0.000204	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—prostate cancer	2.21e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CAV1—prostate cancer	2.2e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LPL—prostate cancer	2.19e-05	0.000201	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KDR—prostate cancer	2.18e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAV1—prostate cancer	2.18e-05	0.000199	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2—prostate cancer	2.17e-05	0.000199	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFRB—prostate cancer	2.17e-05	0.000199	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAP2K1—prostate cancer	2.17e-05	0.000199	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CD—prostate cancer	2.16e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CB—prostate cancer	2.15e-05	0.000197	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—prostate cancer	2.13e-05	0.000195	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—prostate cancer	2.13e-05	0.000195	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—prostate cancer	2.12e-05	0.000195	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITGB3—prostate cancer	2.12e-05	0.000194	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—KRAS—prostate cancer	2.11e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BAD—prostate cancer	2.07e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—prostate cancer	2.07e-05	0.000189	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGF2—prostate cancer	2.06e-05	0.000189	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB3—prostate cancer	2.05e-05	0.000188	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGFR2—prostate cancer	2.05e-05	0.000188	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—prostate cancer	2.04e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APC—prostate cancer	2.01e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—prostate cancer	2.01e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGF—prostate cancer	1.98e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS1—prostate cancer	1.98e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—prostate cancer	1.98e-05	0.000181	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JAK2—prostate cancer	1.98e-05	0.000181	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2—prostate cancer	1.97e-05	0.000181	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TERT—prostate cancer	1.97e-05	0.00018	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—prostate cancer	1.94e-05	0.000178	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MDM2—prostate cancer	1.93e-05	0.000177	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GSK3B—prostate cancer	1.93e-05	0.000176	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB2—prostate cancer	1.9e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—prostate cancer	1.9e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—prostate cancer	1.88e-05	0.000172	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CB—prostate cancer	1.88e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—prostate cancer	1.88e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—prostate cancer	1.86e-05	0.000171	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CREBBP—prostate cancer	1.86e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—prostate cancer	1.84e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CREBBP—prostate cancer	1.84e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—prostate cancer	1.84e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—prostate cancer	1.83e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CAV1—prostate cancer	1.82e-05	0.000167	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—prostate cancer	1.81e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KDR—prostate cancer	1.8e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAP2K1—prostate cancer	1.78e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CD—prostate cancer	1.76e-05	0.000162	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1B—prostate cancer	1.76e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—prostate cancer	1.75e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—prostate cancer	1.75e-05	0.00016	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—prostate cancer	1.75e-05	0.00016	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—prostate cancer	1.74e-05	0.00016	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CD—prostate cancer	1.74e-05	0.00016	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—KRAS—prostate cancer	1.73e-05	0.000158	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—prostate cancer	1.73e-05	0.000158	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2—prostate cancer	1.73e-05	0.000158	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—prostate cancer	1.72e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BAD—prostate cancer	1.71e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF2—prostate cancer	1.69e-05	0.000155	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—prostate cancer	1.68e-05	0.000154	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—prostate cancer	1.67e-05	0.000153	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CTNNB1—prostate cancer	1.67e-05	0.000153	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APC—prostate cancer	1.66e-05	0.000152	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—prostate cancer	1.66e-05	0.000152	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—prostate cancer	1.64e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGF—prostate cancer	1.64e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS1—prostate cancer	1.64e-05	0.00015	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—prostate cancer	1.63e-05	0.00015	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1A—prostate cancer	1.63e-05	0.000149	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTEN—prostate cancer	1.62e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JAK2—prostate cancer	1.62e-05	0.000148	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GSK3B—prostate cancer	1.59e-05	0.000146	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—prostate cancer	1.59e-05	0.000145	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—prostate cancer	1.58e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MDM2—prostate cancer	1.58e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—prostate cancer	1.57e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB2—prostate cancer	1.56e-05	0.000143	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EP300—prostate cancer	1.55e-05	0.000142	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CB—prostate cancer	1.54e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CREBBP—prostate cancer	1.54e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CB—prostate cancer	1.52e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—prostate cancer	1.52e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	1.51e-05	0.000138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SRC—prostate cancer	1.51e-05	0.000138	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—prostate cancer	1.5e-05	0.000138	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	1.48e-05	0.000135	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	1.47e-05	0.000134	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—prostate cancer	1.47e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	1.46e-05	0.000133	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—prostate cancer	1.45e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	1.44e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	1.44e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	1.44e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	1.43e-05	0.000131	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	1.43e-05	0.000131	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—prostate cancer	1.41e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2—prostate cancer	1.41e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—prostate cancer	1.41e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF2—prostate cancer	1.39e-05	0.000128	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—prostate cancer	1.38e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—prostate cancer	1.38e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	1.36e-05	0.000125	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—prostate cancer	1.35e-05	0.000124	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—prostate cancer	1.35e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—prostate cancer	1.34e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JAK2—prostate cancer	1.34e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	1.33e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTEN—prostate cancer	1.33e-05	0.000122	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—prostate cancer	1.32e-05	0.000121	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTEN—prostate cancer	1.31e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.31e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.3e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.3e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.29e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.27e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.27e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—EP300—prostate cancer	1.25e-05	0.000115	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KRAS—prostate cancer	1.25e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.23e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.22e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.2e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.19e-05	0.000109	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.19e-05	0.000109	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.18e-05	0.000108	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.17e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.17e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.16e-05	0.000106	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	1.15e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.14e-05	0.000104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.13e-05	0.000103	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—prostate cancer	1.11e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.1e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.1e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.1e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.1e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.1e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.08e-05	9.9e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.07e-05	9.8e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.05e-05	9.58e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.02e-05	9.35e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—prostate cancer	1.01e-05	9.29e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	9.91e-06	9.07e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	9.81e-06	8.99e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	9.38e-06	8.59e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—prostate cancer	9.35e-06	8.57e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—prostate cancer	9.26e-06	8.48e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—prostate cancer	9.12e-06	8.35e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	9.1e-06	8.33e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—prostate cancer	9.07e-06	8.31e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	8.92e-06	8.17e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	8.42e-06	7.71e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—prostate cancer	8.3e-06	7.6e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	7.74e-06	7.09e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	7.66e-06	7.02e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—prostate cancer	7.56e-06	6.92e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—prostate cancer	7.49e-06	6.86e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—prostate cancer	6.85e-06	6.28e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	6.32e-06	5.79e-05	CbGpPWpGaD
